A Phase IIb/III trial with infants entering their first respiratory syncytial virus (RSV) season met its primary endpoints.

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...

Highlights:,Merck & Co Inc's experimental treatment, clesrovimab, has demonstrated positive results in a mid- to late-stage ...

Albertans can book annual immunizations against respiratory viruses as the fall season approaches. Eligible residents can ...

The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...

A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus (RSV ... STOCK PHOTO/Getty Images Results showed the risk of SUID ...

New images of the virus from researchers at ... Sibert et al, Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers, Nature ...

Study found that influenza vaccination is highly effective in preventing infection and hospitalization in children, though ...

RSV F proteins, shown in this image created by University of Wisconsin ... MADISON — The complex shape of respiratory syncytial virus is one hurdle limiting the development of treatments ...

PFIZER Oct 8, 2024 Oct 8, 2024 Updated Oct 8, 2024 ...

RSV vaccine sales by GSK and Pfizer have dropped in the U.S. after regulators limited the eligible age group, affecting ...